Free Trial
→ Why Some AI Stocks Already Surged Over 300 Percent (From Brownstone Research) (Ad)tc pixel
OTCMKTS:AHKSY

Asahi Kasei Q2 2026 Earnings Results & Report

Asahi Kasei logo
$20.05 +0.10 (+0.50%)
As of 03:50 PM Eastern

Asahi Kasei missed analyst expectations on both earnings and revenue in its Q2 2026 results, released November 5, 2025. The company reported EPS of $0.31 versus the $0.3356 consensus estimate, while revenue of $4.88 billion fell short of the $5.12 billion estimate by $240.74 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens

Asahi Kasei EPS Results

Actual EPS
$0.31
Consensus EPS
$0.3356
Beat/Miss
Missed by -$0.0256
One Year Ago EPS
N/A

Asahi Kasei Revenue Results

Actual Revenue
$4.88 billion
Expected Revenue
$5.12 billion
Beat/Miss
Missed by -$240.74 million
YoY Revenue Growth
N/A

Upcoming Earnings

Asahi Kasei's next earnings date is estimated for Wednesday, November 4, 2026, based on past reporting schedules.

Conference Call Resources

Asahi Kasei Q2 2026 Earnings FAQ

Asahi Kasei (OTCMKTS:AHKSY) reported earnings of $0.31 per share for Q2 2026, missing the consensus estimate of $0.3356. The report was announced on Wednesday, November 5, 2025.

Asahi Kasei reported revenue of $4.88 billion for Q2 2026, against a consensus estimate of $5.12 billion.

Asahi Kasei's next earnings date is estimated for Wednesday, November 4, 2026. MarketBeat tracks confirmed and estimated earnings dates for Asahi Kasei on the company's earnings history page.

Asahi Kasei Earnings Headlines

Asahi Kasei Corp. (OTCMKTS:AHKSY) Stock Short Interest Report for September
October 10, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31105693
Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing
September 15, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260915583092/en/asahi-kasei-introduces-vantij%c2%ae-su-vfc-benchtop-to-improve-efficiency-and-consistency-in-gene-therapy-manufacturing/
“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 years
Dr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.tc pixel
October 16 at 1:00 AM  |  Weiss Ratings (Ad)
Asahi Kasei Corp ADR AHKSY
September 11, 2026  |  morningstar.comM
Asahi Kasei Develops Novel Lithium Pre-doping Technology to Raise Energy Density and Lower Cost of Silicon-rich Lithium-ion Batteries
August 19, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260819788219/en/asahi-kasei-develops-novel-lithium-pre-doping-technology-to-raise-energy-density-and-lower-cost-of-silicon-rich-lithium-ion-batteries/
Asahi Kasei Advances Share Buyback, Plans Cancellation of Repurchased Stock
June 30, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/asahi-kasei-advances-share-buyback-plans-cancellation-of-repurchased-stock?utm_source=marketbeat.com&utm_medium=referral
See More Asahi Kasei Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Asahi Kasei? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Asahi Kasei and other key companies, straight to your email.

About Asahi Kasei

Asahi Kasei (OTCMKTS:AHKSY) Corporation is a diversified Japanese manufacturer serving the material, homes and health care markets. Founded in 1922 and headquartered in Tokyo, the company develops and supplies products ranging from chemicals and performance materials to medical devices and housing-related goods and services.

Its materials operations include petrochemical products, synthetic resins, elastomers, coatings and electronic materials, as well as battery separators and other components used in automobiles, electronics and industrial applications. The company also produces fibers and specialized materials for a variety of commercial and consumer uses.

Through its homes business, Asahi Kasei provides residential construction, remodeling, real estate and related services, particularly in Japan. Its health care activities include pharmaceuticals, medical devices and systems used in areas such as acute care, dialysis and therapeutic treatment. Asahi Kasei serves customers in Japan and international markets through a global network of operations and subsidiaries.

View Asahi Kasei Profile
Earnings Tools